Doseology Sciences Inc. (MOOD.CN)
CAD 0.15
(0.0%)
CAD 0.15
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -235.11 Thousand | -481.05 Thousand | -1.71 Million | -2.36 Million | -129.1 Thousand |
| Net Income | -339.84 Thousand | -1.78 Million | -1.93 Million | -1.62 Million | -431.63 Thousand |
| Depreciation & Amortization | 20.37 Thousand | 66.09 Thousand | 139.53 Thousand | 92.83 Thousand | - |
| Deferred income taxes | - | 265.24 Thousand | 2533.00 | -6000.00 | - |
| Stock-based compensation | - | 83.4 Thousand | 85.92 Thousand | 19.83 Thousand | - |
| Change in working capital | 32.92 Thousand | 136.58 Thousand | -284.27 Thousand | -916.56 Thousand | 302.52 Thousand |
| Other non-cash items | 51.43 Thousand | 749.16 Thousand | 284.44 Thousand | 68.29 Thousand | - |
| Investing Cash Flow | - | - | -7875.00 | -26.05 Thousand | - |
| Investments in PPE | -2.00 | 4.00 | -7875.00 | -170.13 Thousand | - |
| Acquisitions | - | - | 109.08 Thousand | 109.08 Thousand | - |
| Investment purchases | - | - | -144.08 Thousand | 24.53 Thousand | - |
| Sales/Maturities of investments | - | - | 35 Thousand | 35 Thousand | - |
| Other Investing Activities | - | - | - | -24.53 Thousand | - |
| Financing Cash Flow | -6138.00 | -91.88 Thousand | -140.07 Thousand | 5.78 Million | 470 Thousand |
| Debt repayment | - | -91.88 Thousand | -120.3 Thousand | -60 Thousand | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | -275 Thousand | -275 Thousand | - |
| Common Stock Issuance | - | - | 6.22 Million | 6.22 Million | 470 Thousand |
| Other Financing Activities | -6138.00 | -91.88 Thousand | -19.77 Thousand | -99.72 Thousand | - |
| Accounts receivables | 14.79 Thousand | 68.31 Thousand | -56.92 Thousand | - | - |
| Accounts payables | 33.57 Thousand | -76.49 Thousand | -281.76 Thousand | - | - |
| Inventory | -31.11 Thousand | 1802.00 | -38.61 Thousand | -129.23 Thousand | - |
| Other working capital | 15.66 Thousand | 142.96 Thousand | 93.03 Thousand | -787.32 Thousand | - |
| Cash at beginning of period | 1.3 Million | 1.87 Million | 3.73 Million | 340.89 Thousand | - |
| Cash at end of period | 1.06 Million | 1.3 Million | 1.87 Million | 3.73 Million | 340.89 Thousand |
| Capital Expenditure | -2.00 | 4.00 | -7875.00 | -170.13 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -241.25 Thousand | -572.93 Thousand | -1.85 Million | 3.39 Million | 340.89 Thousand |
| Free Cash Flow | -235.12 Thousand | -481.05 Thousand | -1.71 Million | -2.53 Million | -129.1 Thousand |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -109.58 Thousand | -40.53 Thousand | -111.64 Thousand | -78.08 Thousand | -1.78 Million | -1.14 Million |
| Depreciation & Amortization | 797.00 | 797.00 | 797.00 | 17.97 Thousand | 66.09 Thousand | -18.24 Thousand |
| Deferred income taxes | - | - | -119.84 Thousand | -45.18 Thousand | 265.24 Thousand | 259.44 Thousand |
| Stock-based compensation | - | 7441.00 | 50.32 Thousand | 10.76 Thousand | 83.4 Thousand | 60.02 Thousand |
| Change in working capital | 91.36 Thousand | 2980.00 | -51.87 Thousand | -9543.00 | 136.58 Thousand | 20.01 Thousand |
| Other non-cash items | 1683.00 | 6051.00 | 101.07 Thousand | 45.18 Thousand | 749.16 Thousand | 694.48 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -6138.00 | - | 8539.00 | -8539.00 | -91.88 Thousand | 19.46 Thousand |
| Debt repayment | - | - | -8539.00 | -8539.00 | -91.88 Thousand | -18.71 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 750.00 |
| Other Financing Activities | -6138.00 | - | 17.07 Thousand | - | - | - |
| Accounts receivables | 11.11 Thousand | -12.57 Thousand | 25.39 Thousand | -9139.00 | 68.31 Thousand | -5721.00 |
| Accounts payables | 79.47 Thousand | -2218.00 | -47.9 Thousand | 4227.00 | -76.49 Thousand | 30.09 Thousand |
| Inventory | -9924.00 | 17.77 Thousand | -45.4 Thousand | 6443.00 | 1802.00 | -8591.00 |
| Other working capital | 10.7 Thousand | -4.00 | 16.04 Thousand | -11.07 Thousand | 142.96 Thousand | 4233.00 |
| Cash at beginning of period | 1.08 Million | 1.11 Million | 1.23 Million | 1.3 Million | 1.87 Million | 1.41 Million |
| Cash at end of period | 1.06 Million | 1.08 Million | 1.11 Million | 1.23 Million | 1.3 Million | 1.3 Million |
| Capital Expenditure | -4.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -21.87 Thousand | -29.31 Thousand | -122.63 Thousand | -67.42 Thousand | -572.93 Thousand | -111.86 Thousand |
| Free Cash Flow | -15.74 Thousand | -29.31 Thousand | -131.17 Thousand | -58.88 Thousand | -481.05 Thousand | -131.32 Thousand |
SYM
ZRVT
600962
FSNUY
6093
4960